Treatment Options for Benign Thyroid Nodules

Benign thyroid nodules are common findings—detected in up to 65% of adults during routine neck ultrasound examinations—and most remain clinically silent throughout life. When a nodule is confirmed as benign through fine-needle aspiration biopsy (FNA) with cytology classified as Bethesda Category II (benign), management focuses on surveillance rather than intervention, unless symptoms or cosmetic concerns arise.

Current guidelines from the American Thyroid Association (ATA) and European Thyroid Association (ETA) recommend periodic clinical evaluation and ultrasound monitoring. For stable, benign nodules without suspicious sonographic features, follow-up imaging is typically scheduled at 12–24 months. If size increases by more than 50% in volume or 20% in two or more dimensions—or if new concerning ultrasound characteristics emerge—repeat FNA is warranted.

For patients experiencing compressive symptoms—such as dysphagia, dyspnea, or voice changes—or those distressed by visible neck asymmetry, nonsurgical options may be considered. Ultrasound-guided thermal ablation techniques—including radiofrequency ablation (RFA), microwave ablation (MWA), and laser ablation—have demonstrated consistent efficacy in reducing nodule volume (typically 40–80% at 6–12 months) and alleviating symptoms, with low complication rates and high patient satisfaction. These procedures are performed under local anesthesia, require no hospital admission, and preserve thyroid function in nearly all cases.

Thyroid hormone suppression therapy—once commonly used—is no longer recommended for benign nodule management due to lack of proven benefit and potential risks, including atrial fibrillation and bone mineral density loss, particularly in older adults.

Surgical excision remains reserved for rare scenarios: persistent diagnostic uncertainty despite repeated FNA, rapid growth suggestive of malignancy, or severe mechanical compromise unresponsive to ablation. In such cases, lobectomy is preferred over total thyroidectomy when feasible, preserving endogenous thyroid hormone production and minimizing lifelong levothyroxine dependence.